Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference20 articles.
1. Norgren L, Hiatt WR, Dormandy JA, et al. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5–67.
2. Yamazaki T, Goto S, Shigematsu H, et al. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J. 2007;71:995–1003.
3. Tsushima N, Matsuo H, Hayashi T, Homma S. The clinical features and treatment of arteriosclerosis obliterans with diabetes. Diabetes. 1996;45:S101–4.
4. Shigematsu H, Nishibe T, Obitsu Y, et al. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD). Int Angiol. 2010;29:2–13.
5. Lin H, Lee JL, Hou HH, Chung CP, Hsu SP, Juan SH. Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells. J Cell Physiol. 2008;214:434–41.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献